Tricida, Inc.

Informe acción DB:1T7

Capitalización de mercado: €368.0k

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Tricida Dirección

Dirección controles de criterios 3/4

Información clave

Gerrit Klaerner

Chief Executive Officer (CEO)

US$4.7m

Compensación total

Porcentaje del salario del CEO12.8%
Permanencia del CEO9.7yrs
Participación del CEO0.7%
Permanencia media de la dirección3.9yrs
Promedio de permanencia en la Junta Directiva9.3yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Gerrit Klaerner en comparación con los beneficios de Tricida?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2022n/an/a

-US$134m

Jun 30 2022n/an/a

-US$148m

Mar 31 2022n/an/a

-US$153m

Dec 31 2021US$5mUS$600k

-US$177m

Sep 30 2021n/an/a

-US$181m

Jun 30 2021n/an/a

-US$219m

Mar 31 2021n/an/a

-US$244m

Dec 31 2020US$9mUS$598k

-US$265m

Sep 30 2020n/an/a

-US$268m

Jun 30 2020n/an/a

-US$235m

Mar 31 2020n/an/a

-US$213m

Dec 31 2019US$10mUS$584k

-US$177m

Sep 30 2019n/an/a

-US$146m

Jun 30 2019n/an/a

-US$131m

Mar 31 2019n/an/a

-US$120m

Dec 31 2018US$1mUS$503k

-US$103m

Sep 30 2018n/an/a

-US$96m

Jun 30 2018n/an/a

-US$77m

Mar 31 2018n/an/a

-US$60m

Dec 31 2017US$821kUS$425k

-US$41m

Compensación vs. Mercado: Gerrit's total compensation ($USD4.68M) is above average for companies of similar size in the German market ($USD425.34K).

Compensación vs. Ingresos: Gerrit's compensation has been consistent with company performance over the past year.


CEO

Gerrit Klaerner (50 yo)

9.7yrs

Permanencia

US$4,676,490

Compensación

Dr. Gerrit Klaerner, Ph.D. Founded Tricida, Inc.and has been its Chief Executive Officer and President since August 2013 and has been its an Executive Director since July 2013. Dr. Klaerner was the Founder...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Gerrit Klaerner
Founder9.7yrsUS$4.68m0.68%
$ 2.5k
Geoffrey Parker
COO, CFO & Executive VP6yrsUS$2.51m0.72%
$ 2.7k
Robert McKague
Executive VP3.1yrsUS$2.43m0.031%
$ 112.3
Dawn Parsell
Executive Vice President of Clinical Development4.7yrsUS$2.77m0.0060%
$ 22.0
Annie Yoshiyama
VP of Finance & Chief Accounting Officer2.3yrssin datossin datos
Jackie Cossmon
Vice President of Investor Relations & Communicationsno datasin datossin datos
Edward Hejlek
Executive Vice President of Intellectual Property3.1yrsUS$2.10msin datos

3.9yrs

Permanencia media

57yo

Promedio de edad

Equipo directivo experimentado: 1T7's management team is considered experienced (3.9 years average tenure).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Gerrit Klaerner
Founder9.8yrsUS$4.68m0.68%
$ 2.5k
Kathryn Falberg
Independent Non-Employee Director4.9yrsUS$329.00k0.074%
$ 271.2
Klaus Veitinger
Independent Chairman of the Board9.2yrsUS$379.00k0.20%
$ 723.3
David Hirsch
Independent Non-Employee Director6.8yrsUS$326.50k0.019%
$ 70.9
Robert Alpern
Member of Scientific & Clinical Advisory Board and Independent Non-Employee Director9.5yrsUS$314.00k0%
$ 0
John Fordtran
Member of Scientific & Clinical Advisory Boardno datasin datossin datos
David Bushinsky
Member of Scientific & Clinical Advisory Boardno datasin datossin datos
Craig Hawker
Member of Scientific & Clinical Advisory Boardno datasin datossin datos
Sandra Coufal
Independent Non-Employee Director and Member of Scientific & Clinical Advisory Board9.8yrsUS$316.50k0.15%
$ 554.7
Navdeep Tangri
Member of Scientific & Clinical Advisory Boardno datasin datossin datos
Thomas Hostetter
Member of Scientific & Clinical Advisory Boardno datasin datossin datos
Bertram Pitt
Member of Scientific and Clinical Advisory Boardno datasin datossin datos

9.3yrs

Permanencia media

59yo

Promedio de edad

Junta con experiencia: 1T7's board of directors are considered experienced (9.3 years average tenure).